Open Access

PP2B and ERK1/2 regulate hyaluronan synthesis of HT168 and WM35 human melanoma cell lines

  • Authors:
    • Éva Katona
    • Tamás Juhász
    • Csilla Szűcs Somogyi
    • Tibor Hajdú
    • Csaba Szász
    • Kálmán Rácz
    • Endre Kókai
    • Pál Gergely
    • Róza Zákány
  • View Affiliations

  • Published online on: December 28, 2015     https://doi.org/10.3892/ijo.2015.3313
  • Pages: 983-997
  • Copyright: © Katona et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Hyaluronan (HA) is the major glycosaminoglycan component of the extracellular matrix in either normal or malignant tissues and it may affect proliferation, motility and differentiation of various cell types. Three isoforms of plasma membrane-bound hyaluronan synthases (HAS 1, 2 and 3) secrete and simultaneously bind pericellular HA. HAS enzymes are subjects of post-translational protein phosphorylation which is believed to regulate their enzymatic activity. In this study, we investigated the HA homeostasis of normal human epidermal melanocytes, HT168 and WM35 human melanoma cell lines and melanoma metastases. HAS2 and HAS3 were detected in all the samples, while the expression of HAS1 was not detectable in any case. Malignant tissue samples and melanoma cell lines contained extra- and intracellular HA abundantly but not normal melanocytes. Applying HA as a chemoattractant facilitated the migration of melanoma cells in Boyden chamber. The amount of HA was reduced upon the inhibition of calcineurin with cyclosporine A (CsA), while the inhibition of ERK1/2 with PD098059 elevated it in both cell lines. The signals of Ser/Thr phosphoproteins at 57 kD were stronger after CsA treatment, while a markedly weaker signal was detected upon inhibition of the MAPK pathway. Our results suggest opposing effects of the two investigated enzymes on the HA homeostasis of melanoma cells. We propose that the dephosphorylation of HAS enzymes targeted by PP2B augments HA production, while their phosphorylation by the activity of MAPK pathway reduces HA synthesis. As the expression of the HA receptor RHAMM was also significantly enhanced by PD098059, the MAPK pathway exerted a complex attenuating effect on HA signalling in the investigated melanoma cells. This observation suggests that the application of MAPK-ERK pathway inhibitors requires a careful therapeutic design in melanoma treatment.
View Figures
View References

Related Articles

Journal Cover

March 2016
Volume 48 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Katona, É., Juhász, T., Somogyi, C.S., Hajdú, T., Szász, C., Rácz, K. ... Zákány, R. (2016). PP2B and ERK1/2 regulate hyaluronan synthesis of HT168 and WM35 human melanoma cell lines. International Journal of Oncology, 48, 983-997. https://doi.org/10.3892/ijo.2015.3313
MLA
Katona, É., Juhász, T., Somogyi, C. S., Hajdú, T., Szász, C., Rácz, K., Kókai, E., Gergely, P., Zákány, R."PP2B and ERK1/2 regulate hyaluronan synthesis of HT168 and WM35 human melanoma cell lines". International Journal of Oncology 48.3 (2016): 983-997.
Chicago
Katona, É., Juhász, T., Somogyi, C. S., Hajdú, T., Szász, C., Rácz, K., Kókai, E., Gergely, P., Zákány, R."PP2B and ERK1/2 regulate hyaluronan synthesis of HT168 and WM35 human melanoma cell lines". International Journal of Oncology 48, no. 3 (2016): 983-997. https://doi.org/10.3892/ijo.2015.3313